camonsertib,Niraparib,Olaparib,Talazoparib
repare therapeutics,roche,gsk,astrazeneca,merck,pfizer
['tresr', 'camonsertib', 'repare therap', 'repare,(-prepare)']
$rptx repare therapeutics presents initial clinical data from the phase 1/2 tresr and attacc trials evaluating camonsertib in combination with three parp inhibitors at the 2023 aacr annual meeting 1/3
¬ Retweeting Bloomberg's Feed all in one place.

¬ Market & Stock Updates

¬ I'm Barry Bloomberg putting out the fastest updates!

¬ Making your life easier.